UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Tumour‐induced immune suppression: role of inflammatory mediators released by myelomonocytic cells

Journal of internal medicine, 2014-08, Vol.276 (2), p.154-170

2014

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

Cancer Immunology, Immunotherapy, 2012-06, Vol.61 (6), p.827-838

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

Journal of translational medicine, 2016-07, Vol.14 (1), p.227-227, Article 227

2016

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

Cancer Immunology, Immunotherapy, 2012-06, Vol.61 (6), p.827-838

2012

Link zum Volltext

Verfügbarkeit prüfen

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy

Nature biotechnology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients

International journal of cancer, 2012-10, Vol.131 (7), p.1611-1620

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Leukemia, 2013-02, Vol.27 (2), p.377-388

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function

International journal of cancer, 2012-07, Vol.131 (1), p.129-139

2012

Link zum Volltext

Verfügbarkeit prüfen

On the armament and appearances of human myeloid-derived suppressor cells

Clinical immunology (Orlando, Fla.), 2012-09, Vol.144 (3), p.250-268

2012

Link zum Volltext

Verfügbarkeit prüfen

Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

Cancer research (Chicago, Ill.), 2010-06, Vol.70 (11), p.4335-4345

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Leukemia, 2012-07, Vol.27 (2), p.377-388

2012

Link zum Volltext

Verfügbarkeit prüfen

Camouflage and sabotage: tumor escape from the immune system

Cancer Immunology, Immunotherapy, 2011-08, Vol.60 (8), p.1161-1171

2011

Link zum Volltext

Verfügbarkeit prüfen

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2-Dependent Mechanisms

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13), p.3877-3887

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

The Journal of immunology (1950), 2009-10, Vol.183 (8), p.4921-4930

2009

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Oncotarget, 2017-03, Vol.8 (13), p.21539-21553

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

Journal of translational medicine, 2013-11, Vol.11 (1), p.290-290, Article 290

2013

Link zum Volltext

Verfügbarkeit prüfen

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (45), p.17481-17486

2008

Link zum Volltext

Verfügbarkeit prüfen

2320P Detection of gene fusion-induced neoepitopes in dedifferentiated liposarcoma

Annals of oncology, 2023-10, Vol.34, p.S1185-S1185

2023

Link zum Volltext

Verfügbarkeit prüfen

Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007

Cancer Immunology, Immunotherapy, 2008-04, Vol.57 (4), p.593-599

2008

Link zum Volltext

Verfügbarkeit prüfen

P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB)

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii46-ii46

2023

Link zum Volltext

Verfügbarkeit prüfen

8P Pre-treatment blood gene expression changes associated with durable clinical benefit in metastatic non-small cell lung cancer with high PD-L1 expression receiving first-line pembrolizumab

Annals of oncology, 2021-12, Vol.32, p.S1377-S1378

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma

Cancer Immunology, Immunotherapy, 2014-10, Vol.63 (10), p.1061-1071

2014

Link zum Volltext

Verfügbarkeit prüfen

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display

Frontiers in immunology, 2019-12, Vol.10, p.2766-2766

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(169)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(194)
Japanisch
(18)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumour‐induced immune suppression: role of inflammatory mediators released by myelomonocytic cells

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy

Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study

On the armament and appearances of human myeloid-derived suppressor cells

Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Camouflage and sabotage: tumor escape from the immune system

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2-Dependent Mechanisms

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

2320P Detection of gene fusion-induced neoepitopes in dedifferentiated liposarcoma

Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007

P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB)

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

8P Pre-treatment blood gene expression changes associated with durable clinical benefit in metastatic non-small cell lung cancer with high PD-L1 expression receiving first-line pembrolizumab

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display

Suchergebnisse filtern